news
CRISPR Epigenome Editing Shows Promise for Treating Disease
Researchers are using CRISPR technology to edit the epigenome, which controls gene expression without changing the underlying DNA code. This method is being explored to treat diseases by switching genes on or off, potentially offering a new therapeutic avenue. The approach targets the regulatory layers of our genetic material, not the genes themselves.
Researchers are using CRISPR technology to edit the epigenome, which controls gene expression without changing the underlying DNA code. This method is being explored to treat diseases by switching genes on or off, potentially offering a new therapeutic avenue. The approach targets the regulatory layers of our genetic material, not the genes themselves.
The architecture take
Think of it as fine-tuning your body's software—telling certain programs to run or pause, without rewriting the whole operating system. This could mean a future where we fix health problems by simply flipping molecular switches, influencing things like inflammation or cell repair.